StockData
Lifeward Ltd. logo

Lifeward Ltd. (LFWD) stock

LFWDNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3078% below fair value
$3.20+0.10 (+3.23%)

Close on Nov 18, 2026Market cap $9.06MP/E –Yield –

Earnings

Lifeward's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 17, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$5.40M
-12.9% on a year earlier
adjusted net loss per share, Q3 FY2026
-$1.44
-$0.19 a year earlier
Latest guidance
Raised
Nov 14, 2025 · 2 items

Quarterly results

Revenue and earnings per share from each of Lifeward's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 17, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 13, 2026before the open$5.40M-12.9%-$1.32-$1.44Release
Q2 FY2026ended Jun 30, 2026Aug 14, 2026before the open$6.60M+15.8%-$4.12-$1.46Release
Q1 FY2026ended Mar 31, 2026May 15, 2026before the open$3.90M-22.0%-$6.70-$3.13Release
Q4 FY2025ended Dec 31, 2025Mar 18, 2026before the open$5.10M-32.0%-$3.60-$2.85Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025before the open$6.20M+1.6%-$0.20-$0.19Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$5.70M-14.9%-$0.58-$0.31Release
Q1 FY2025ended Mar 31, 2025May 15, 2025before the open$5.00M-5.7%-$0.46-$0.44Release
Q4 FY2024ended Dec 31, 2024Mar 7, 2025before the open$7.50M+8.7%-$1.73-$0.38Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$6.10M+38.6%-$0.35-$0.45Release
Q2 FY2024ended Jun 30, 2024Aug 15, 2024before the open$6.70M+415.4%-$0.50-$0.42Release
Q1 FY2024ended Mar 31, 2024May 15, 2024before the open$5.30M+341.7%$0.73$0.62Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Lifeward guided for has been reported

Guidance vs results

The last range Lifeward gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q1 FY2024Revenue$5.00M – $5.50M$5.30MWithin range

Guidance history

Every forecast Lifeward put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 14, 2025projected non-GAAP net lossFY2025$12.00M – $14.00MRaised
Nov 14, 2025expected revenueFY2025$24.00M – $26.00MReaffirmed
Aug 14, 2025non-GAAP net lossFY2025-$14.00M – -$12.00MLowered
Aug 14, 2025revenueFY2025$24.00M – $26.00MLowered
Mar 7, 2025adjusted gross marginsFY202547% – 49%New
Mar 7, 2025quarterly adjusted operating lossQ4 FY2025$1.00MNew
Mar 7, 2025non-GAAP operating lossFY2025$7.00M – $9.00MNew
Mar 7, 2025non-GAAP operating expensesFY2025$22.00M – $23.00MNew
Mar 7, 2025revenueFY2025$28.00M – $30.00MNew
Nov 12, 2024revenueFY2024$25.00M – $26.00MLowered
Aug 15, 2024revenueFY2024$28.00M – $32.00MReaffirmed
May 15, 2024revenueFY2024$28.00M – $32.00MReaffirmed
Feb 27, 2024revenueQ1 FY2024$5.00M – $5.50MNew
Feb 27, 2024revenueFY2024$28.00M – $32.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Lifeward filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Results
  5. Results
  6. Update
  7. Results
  8. Results
  9. Results
  10. News
  11. Results
  12. News
  13. News
  14. Results
  15. Results

See a number that looks wrong?